<?xml version="1.0"?>
<body status="ih"><p nid="t0:ih:1">HR 27 IH</p><p/><center><p nid="t0:ih:2">113th CONGRESS</p></center>
<p/><center><p nid="t0:ih:3">1st Session</p></center>
<p/><center><p nid="t0:ih:4">H. R. 27</p></center>
<p nid="t0:ih:5">To amend title XVIII of the Social Security Act to repeal the Medicare competitive acquisition program for durable medical equipment and prosthetics, orthotics, and supplies (DMEPOS), and for other purposes.</p><p/><center><p nid="t0:ih:6">IN THE HOUSE OF REPRESENTATIVES</p></center>
<p/><h3 nid="t0:ih:7"><center><p nid="t0:ih:8">January 3, 2013</p></center></h3>
<p nid="t0:ih:9">Ms. VELAZQUEZ introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, the Judiciary, and Small Business, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned</p><hr/><p/><center><p nid="t0:ih:10">A BILL</p></center>
<p nid="t0:ih:11">To amend title XVIII of the Social Security Act to repeal the Medicare competitive acquisition program for durable medical equipment and prosthetics, orthotics, and supplies (DMEPOS), and for other purposes.</p><ul><p nid="t0:ih:12"><em>  Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,</em></p></ul><p/><h3 nid="t0:ih:13">SECTION 1. SHORT TITLE.</h3>
<ul><p nid="t0:ih:14">This Act may be cited as the &#x2018;Small Supplier Fairness in Bidding Competition Act of 2013&#x2019;.</p></ul><p/><h3 nid="t0:ih:15">SEC. 2. REPEAL OF MEDICARE DMEPOS COMPETITIVE ACQUISITION PROGRAM.</h3>
<ul><p nid="t0:ih:16">(a) In General- Section 1847 of the Social Security Act (<usc-reference title="42" section="1395w-3" paragraph="">42 U.S.C. 1395w-3</usc-reference>) is repealed.</p><p nid="t0:ih:17">(b) Effective Date-</p><ul><p nid="t0:ih:18">(1) IN GENERAL- The repeal made by subsection (a) shall take effect on the date of the enactment of this Act.</p><p nid="t0:ih:19">(2) IMPACT ON CURRENT CONTRACTS- In the case of any contract awarded under section 1847 of the Social Security Act before the date of the repeal of such section--</p><ul><p nid="t0:ih:20">(A) the contract is terminated;</p><p nid="t0:ih:21">(B) no payment shall be made under title XVIII of such Act on or after the date of the enactment of this Act based on such a contract; and</p><p nid="t0:ih:22">(C) to the extent that any damages may be applicable as a result of the termination of such contracts, such damages shall be payable from the Federal Supplementary Medical Insurance Trust Fund under section 1841 of such Act.</p></ul><p nid="t0:ih:23">(3) CONSTRUCTION- Nothing in this subsection shall be construed to provide an independent cause of action or right to administrative or judicial review with regard to the termination provided under this subsection.</p></ul><p nid="t0:ih:24">(c) Report- Not later than one year after the date of the enactment of this Act, the Administrator of the Centers for Medicare &amp; Medicaid Services shall submit to the Committee on Small Business of the House of Representatives and the Committee on Small Business and Entrepreneurship of the Senate a report providing an analysis of the impact of competitive bidding on small clinical laboratories.</p></ul><p/><h3 nid="t0:ih:25">SEC. 3. SMALL BUSINESS ADVOCACY REVIEW PANELS.</h3>
<ul><p nid="t0:ih:26"><usc-reference title="5" section="609" paragraph="d">Section 609(d) of title 5, United States Code</usc-reference>, is amended--</p><ul><p nid="t0:ih:27">(1) in paragraph (2), by striking at the end &#x2018;and&#x2019;;</p><p nid="t0:ih:28">(2) in paragraph (3), by striking the period at the end and inserting &#x2018;; and&#x2019;; and</p><p nid="t0:ih:29">(3) by adding at the end the following new paragraph:</p><blockquote><p nid="t0:ih:30">&#x2018;(4) the Centers for Medicare &amp; Medicaid Services of the Department of Health and Human Services (solely with respect to its capacity to issue rules governing the Medicare part B fee schedule for clinical laboratory services).&#x2019;.</p></blockquote></ul></ul></body>
